Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-04 Sale |
2023-01-04 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
3,584 | $1.694 | $6,071 | 5,781 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,100 | $1.694 | $1,863 | 1,725 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
876 | $1.694 | $1,484 | 1,361 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
5,073 | $1.694 | $8,594 | 6,631 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-01 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,536 | $1.9689 | $4,993 | 3,316 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-01 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
2,983 | $1.7735 | $5,290 | 4,829 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-01 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
21,040 | $1.7735 | $37,314 | 34,824 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-05 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,973 | $1.6781 | $3,311 | 3,104 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-27 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,562 | $1.63 | $4,176 | 3,290 (Direct) |
View |
| 2022-05-20 Purchase |
2022-05-23 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer |
39,000 | $0.2904 | $11,326 | 96,000 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 9:04 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
4,368 | $3.1918 | $13,942 | 7,336 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 9:03 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,368 | $3.1918 | $13,942 | 7,336 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,121 | $3.1918 | $6,770 | 3,529 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
11,096 | $3.1918 | $35,416 | 12,312 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
6,018 | $3.552 | $21,376 | 3,754 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,846 | $3.5539 | $17,222 | 1,749 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
4,624 | $3.5544 | $16,435 | 1,383 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
17,408 | $3.5545 | $61,877 | 3,356 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 9:08 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
3,490 | $4.0642 | $14,184 | 5,873 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 9:06 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,070 | $4.0642 | $4,349 | 1,755 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 9:05 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
849 | $4.0642 | $3,451 | 1,388 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 9:04 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
5,532 | $4.0642 | $22,483 | 6,172 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-01 Option Award |
2022-07-01 5:18 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
737,050 | $0 | 737,050 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:03 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:03 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
816,067 | $0 | 816,067 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:02 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Furey John Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:02 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Noble James Director |
710,711 | $0 | 710,711 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:01 pm |
2023-07-01 2032-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
737,050 | $0 | 737,050 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:01 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:00 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
1,000,439 | $0 | 1,000,439 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-04 9:03 pm |
N/A 2032-05-04 |
Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer |
557,304 | $0 | 557,304 (Direct) |
View |
| 2022-01-31 Option Award |
2022-01-31 9:05 pm |
N/A 2032-01-31 |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
4,466,376 | $0 | 4,466,376 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:04 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,721,328 | $0 | 1,721,328 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:03 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,721,328 | $0 | 1,721,328 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:03 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer |
1,721,328 | $0 | 1,721,328 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:02 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,581,968 | $0 | 2,581,968 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:00 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
1,721,328 | $0 | 1,721,328 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:00 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
5,737,704 | $0 | 5,737,704 (Direct) |
View |